Grantham, Mayo, Van Otterloo & Co (GMO)’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$860K Buy
20,894
+304
+1% +$11.5K ﹤0.01% 532
2026
Q1
$736K Buy
20,590
+7,089
+53% +$258K ﹤0.01% 532
2025
Q4
$438K Buy
13,501
+1,040
+8% +$32.5K ﹤0.01% 589
2025
Q3
$352K Sell
12,461
-3,899
-24% -$112K ﹤0.01% 550
2025
Q2
$493K Sell
16,360
-1,434
-8% -$48.6K ﹤0.01% 540
2025
Q1
$728K Sell
17,794
-8,353
-32% -$402K ﹤0.01% 487
2024
Q4
$1.42M Buy
26,147
+448
+2% +$25.7K ﹤0.01% 399
2024
Q3
$1.67M Sell
25,699
-2,683
-9% -$172K 0.01% 388
2024
Q2
$1.76M Buy
28,382
+1,101
+4% +$76.5K 0.01% 371
2024
Q1
$2.31M Sell
27,281
-6,482
-19% -$514K 0.01% 356
2023
Q4
$2.53M Buy
33,763
+280
+0.8% +$19.4K 0.01% 338
2023
Q3
$2.32M Buy
33,483
+1,980
+6% +$141K 0.01% 396
2023
Q2
$2.29M Sell
31,503
-1,363
-4% -$92.1K 0.01% 433
2023
Q1
$2.36M Sell
32,866
-8,000
-20% -$612K 0.01% 403
2022
Q4
$3.05M Buy
40,866
+19,866
+95% +$1.42M 0.02% 394
2022
Q3
$1.38M Buy
+21,000
New +$1.61M 0.01% 465
2018
Q3
Sell
-17,558
Closed -$1.9M 540
2018
Q2
$1.9M Buy
+17,558
New +$1.89M 0.01% 315
2013
Q3
Sell
-4,297
Closed -$318K 672
2013
Q2
$318K Buy
+4,297
New +$288K ﹤0.01% 587

Other funds holding CRI

Grantham, Mayo, Van Otterloo & Co (GMO)'s CRI Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Carter's (CRI) stake by 1.5% in Q2 2026, buying an estimated $11.5K and bringing the position to 20,894 shares worth $860K. The position accounts for ﹤0.01% of the portfolio, ranked #532.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CRI in Q2 2013 and has held it in 18 quarters since. The position peaked at $3.05M in Q4 2022. 287 funds tracked by Wall St. Rank hold CRI as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 20,894 shares of Carter's worth $860K as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 304 Carter's shares in Q2 2026, an estimated $11.5K.
  • Carter's made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #532 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Carter's in Q2 2013 and has held it in 18 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Carter's position peaked at $3.05M in Q4 2022.
  • 287 funds tracked by Wall St. Rank held Carter's as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.